| CTRI Number |
CTRI/2025/03/081629 [Registered on: 04/03/2025] Trial Registered Prospectively |
| Last Modified On: |
28/02/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Environmental surveillance, Cohort and Cross-sectional study. |
| Study Design |
Other |
|
Public Title of Study
|
Monitoring wastewater for identifying multiple microorganisms in Vellore |
|
Scientific Title of Study
|
Vellore multipathogen Wastewater based Environmental Surveillance |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Venkata Raghava Mohan |
| Designation |
Professor and Head |
| Affiliation |
Christian Medical College |
| Address |
Department of Community Medicine, Christian Medical College, Vellore
Vellore TAMIL NADU 632002 India |
| Phone |
09443109044 |
| Fax |
04162262788 |
| Email |
venkat@cmcvellore.ac.in |
|
Details of Contact Person Scientific Query
|
| Name |
Venkata Raghava Mohan |
| Designation |
Professor and Head |
| Affiliation |
Christian Medical College |
| Address |
Department of Community Medicine, Christian Medical College, Vellore
TAMIL NADU 632002 India |
| Phone |
09443109044 |
| Fax |
04162262788 |
| Email |
venkat@cmcvellore.ac.in |
|
Details of Contact Person Public Query
|
| Name |
Venkata Raghava Mohan |
| Designation |
Professor and Head |
| Affiliation |
Christian Medical College |
| Address |
Department of Community Medicine, Christian Medical College, Vellore
TAMIL NADU 632002 India |
| Phone |
09443109044 |
| Fax |
04162262788 |
| Email |
venkat@cmcvellore.ac.in |
|
|
Source of Monetary or Material Support
|
| Bill and Melinda Gates Foundation, USA |
|
|
Primary Sponsor
|
| Name |
Bill and Melinda Gates Foundation, USA |
| Address |
P. O. Box 23350, Seattle
Washington 98102, USA |
| Type of Sponsor |
Other [Private Foundation] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Venkata Raghava Mohan |
Christian Medical College and Vellore Hospital |
Department of Community Medicine, Vellore College Campus
Thorapadi Post, Bagayam, Vellore, 632012 Vellore TAMIL NADU |
04162284207 04162262788 venkat@cmcvellore.ac.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Review Board, Christian Medical College, Thorapadi Post, Bagayam Vellore, Tamil Nadu 632012 |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Family members above 15 years for TB survey. Adults and children volunteers for cholera sero survey |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
0.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
Healthy volunteers willing to participate in a longitudinal serosurvey among 1080 rural and 1080 urban participants to estimate the seroincidence of Vibrio cholerae in the community.
All individuals above the age of 15 years from ~20,000 families in urban areas and all families from rural areas (three or four villages of Kaniyambadi block bordering Jawadhi hills) where wastewater surveillance is implemented for estimating the burden of pulmonary tuberculosis and drug-resistant tuberculosis. |
|
| ExclusionCriteria |
| Details |
If the participants is not willing to participate in the study. Refuse to provide consent. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Detection rates of Salmonella typhi - Waste water surveillance. |
Fortnightly - two months from 54 urban sites followed by 20 urban sites for 30 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Detection rates of avian influenza virus - Waste water & samples from poultry markets. |
Fortnightly - 50 sampling location including 25 waste water sampling locations and 25 from poultry markets (20 urban & five rural areas in each) for 32 months |
| Detection rates of Vibrio cholerae - Waste water surveillance. |
Fortnightly - 25 waste water sampling locations (20 urban & five rural) for 32 months |
| Seroincidence for cholera - Dried blood spots. |
3 time points; baseline, 4-6 months, 10-12 months. Cohort of 1080 participants from rural and urban area |
| Detection rates of MTBC, and TB AMR genes - Waste water surveillance. |
Fortnightly - 25 waste water sampling locations (20 urban & five rural) for 32 months |
| Prevalence of PTB, MDR-TB, and XDR TB in the community - Symptom screening & Sputum testing. |
Individuals above 15 years from ~20,000 families from urban areas and all families in the rural villages. All individuals screened positive for their symptom will be sputum tested |
|
|
Target Sample Size
|
Total Sample Size="78726" Sample Size from India="78726"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
17/03/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Wastewater-based
surveillance has become a vital tool in public health monitoring, drawing on
years of environmental surveillance efforts for pathogens like poliovirus. The
majority of the wastewater surveillance conducted across the globe is mostly
focused on monitoring single pathogens. The ongoing wastewater surveillance in
Vellore City under the Department of Community Health since 2022, is mainly aimed
at establishing baseline detection rates across different sampling sites for Salmonella
typhi and Salmonella paratyphi A in the environment and monitoring
longitudinal trends after phased TCV introduction in the study area as part of
the Vellore Typhoid Vaccine Impact Trial.
Wastewater surveillance for Salmonella typhi and Salmonella paratyphi
A
This proposal will
leverage the existing environmental surveillance to a multiple-pathogen-based
environmental surveillance model. In this proposal, we plan to extend the
current Salmonella typhi and Salmonella paratyphi A surveillance
at 20 sites from the urban wards, for an additional 30 months after the
extension of current surveillance at 54 sites for an additional two months
(August-September 2025). These 20 sites will be selected based on the previous
performance in detecting Salmonella typhi and suitability
for monitoring other pathogens.
Wastewater
surveillance for avian influenza
In addition, we
will implement wastewater (WW) surveillance for avian influenza. Fortnightly WW samples will be collected from 50 sampling
locations (predominantly urban with important rural landmarks) on the sewage
networks, poultry markets, and large retail poultry shops, and swabs from bird
markets (surface swabs of cages, fecal samples, areas with fecal contamination)
for a period of 32 months. This surveillance will allow us to detect the circulating strains of the
influenza virus in the study area, study temporal trends, and compare
rural-urban prevalence.
Wastewater
surveillance for Vibrio cholerae
For Vibrio
cholerae, we will be collecting fortnightly WW samples from 25 community
sampling locations (20 urban and five rural) in Vellore for 32 months. Baseline
rates of environmental detection of Vibrio cholerae will be estimated and
this will enable urban and rural comparisons.
Serosurveillance
surveillance for Vibrio cholerae
Additionally, we
will be conducting a longitudinal serosurvey among 1080 rural and 1080 urban
participants to estimate the seroincidence of Vibrio cholerae in the
community by assessing the levels of Vibrio cholerae-specific
antibodies. We will be collecting dried blood spots at baseline, 4-6 months,
and 10-12 months into the study for this purpose. We will be assessing the
association between the seroincidence of cholera and overall WW positivity,
adjusting for the population size.
Wastewater surveillance for MTBC and AMR genes associated with MTB
resistance (MDR and XDR)
We will also
collect fortnightly WW samples to detect MTBC and AMR genes associated with MTB
resistance (MDR and XDR), to monitor trends in the five rural
and the 20 urban wastewater sampling sites for 32 months.
Community burden
of pulmonary tuberculosis and drug-resistant tuberculosis
A community
screening based on symptoms for pulmonary tuberculosis (PTB) will be conducted
among all individuals above the age of 15 years from ~20,000 families in urban
areas and all families from rural areas (three or four villages of Kaniyambadi
block bordering Jawadhi hills) where wastewater surveillance is implemented. A sputum sample will be collected from those who are positive for symptoms
of PTB from their houses and will be processed by the GeneXpert test, a highly
advanced molecular diagnostic test that detects PTB and determines drug resistance,
especially for rifampicin, which can indicate the presence of multi-drug-resistant
TB. Samples testing positive by the GeneXpert test will be tested using the
Xpert MTB/XDR assay, which can detect extensive drug resistance. |